Health Care · Pharmaceutical Preparations · NYSE · CIK 894158 · no price history on file
Price series unavailable — No prices available for TOVX in [1900-01-01, 2026-07-31]. This symbol may require bring-your-own-key (BYOK) data.
| Days to cover1.0d |
Short interest is FINRA semi-monthly, settlement 2026-07-15.
TOVX is not in the screener universe.
No return windows available for TOVX.
No risk analytics available for TOVX.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 450,263 | $88,161 | — | +112.3% |
| Virtu Financial LLC | 253,218 | $50,000 | — | new |
| VANGUARD FIDUCIARY TRUST CO | 241,780 | $47,389 | — | new |
| UBS Group AG | 225,624 | $44,223 | — | +17.9% |
| VANGUARD CAPITAL MANAGEMENT LLC | 192,404 | $37,711 | — | new |
| JANE STREET GROUP, LLC | 177,034 | $34,664 | — | new |
| Ikarian Capital, LLC | 112,076 | $21,944 | — | +0.0% |
| TWO SIGMA SECURITIES, LLC | 105,241 | $20,606 | — | +145.4% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total. % of shares outstanding not shown: no SEC cover-page share count falls within 120 days of the 2026-Q1 quarter end, so any percentage would rest on a count that cannot speak for this quarter. Holder share counts are shown as filed.
No reported quarters on file for TOVX.
